Gabriel I. Giancaspro

1.5k total citations
27 papers, 894 citations indexed

About

Gabriel I. Giancaspro is a scholar working on Complementary and alternative medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Gabriel I. Giancaspro has authored 27 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Complementary and alternative medicine, 10 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Gabriel I. Giancaspro's work include Complementary and Alternative Medicine Studies (9 papers), Pharmacology and Obesity Treatment (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Gabriel I. Giancaspro is often cited by papers focused on Complementary and Alternative Medicine Studies (9 papers), Pharmacology and Obesity Treatment (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Gabriel I. Giancaspro collaborates with scholars based in United States, Canada and China. Gabriel I. Giancaspro's co-authors include Robin J. Marles, Tieraona Low Dog, Gail B. Mahady, Paula Gardiner, Mary L. Chavez, Marilyn Barrett, Nandakumara Sarma, Linda S. Pellicore, Dandapantula N. Sarma and Jaap Venema and has published in prestigious journals such as Journal of Nutrition, Critical Reviews in Food Science and Nutrition and Clinical Pharmacology & Therapeutics.

In The Last Decade

Gabriel I. Giancaspro

27 papers receiving 853 citations

Peers

Countries citing papers authored by Gabriel I. Giancaspro

Since Specialization

Citations

This map shows the geographic impact of Gabriel I. Giancaspro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel I. Giancaspro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel I. Giancaspro more than expected).

Fields of papers citing papers by Gabriel I. Giancaspro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel I. Giancaspro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel I. Giancaspro. The network helps show where Gabriel I. Giancaspro may publish in the future.

Co-authorship network of co-authors of Gabriel I. Giancaspro

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel I. Giancaspro. A scholar is included among the top collaborators of Gabriel I. Giancaspro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel I. Giancaspro. Gabriel I. Giancaspro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmaceutical analysis by NMR can accommodate strict impurity thresholds: The case of choline 2022 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Matthias Niemitz, J. Brent Friesen, (unknown), Anton Bzhelyansky, Gabriel I. Giancaspro, Shao‐Nong Chen, Guido F. Pauli	12
2	Understanding plant to extract ratios in botanical extracts 2022 ·Frontiers in Pharmacology ·Marı́a Monagas, Thomas Brendler, Josef A. Brinckmann, (unknown), Stefan Gafner, Gabriel I. Giancaspro, (unknown), (unknown), Cuiying Ma, Hellen Oketch‐Rabah, Pilar Pais, Nandakumara Sarma, Robin J. Marles	33
3	Use of qNMR to determine HPLC relative response factors for botanical reference standards used in pharmacopeial monographs 2022 ·Journal of Pharmaceutical and Biomedical Analysis ·Cuiying Ma, Yang Liu, (unknown), Gabriel I. Giancaspro, (unknown)	4
4	What Should Clinicians Know About Dietary Supplement Quality? 2022 ·The AMA Journal of Ethic ·(unknown), (unknown), Nandakumara Sarma, Hellen Oketch‐Rabah, (unknown), Gabriel I. Giancaspro	2
5	Development and Validation of a Species-specific PCR Method for the Identification of Ginseng Species Using Orthogonal Approaches 2021 ·Planta Medica ·Zhengfei Lu, Sara M. Handy, Ning Zhang, Quan Zheng, Qun Xu, Michael Ambrose, Gabriel I. Giancaspro, Nandakumara Sarma	8
6	An Effective Workflow for Differentiating the Same Genus Herbs of Chrysanthemum morifolium Flower and Chrysanthemum Indicum Flower 2021 ·Frontiers in Pharmacology ·Jiao He, Qian Zhang, Cuiying Ma, Gabriel I. Giancaspro, Kaishun Bi, Qing Li	10
7	Multi-Criteria Decision Analysis Model for Assessing the Risk from Multi-Ingredient Dietary Supplements (MIDS) 2020 ·Journal of Dietary Supplements ·Hellen Oketch‐Rabah, Mary Hardy, Allison P. Patton, Mei Chung, Nandakumara Sarma, (unknown), (unknown), Mary A. Fox, Scott A. Jordan, Mkaya Mwamburi, Diane R. Mould, (unknown), Corey J. Hilmas, Ram C. Tiwari, Luis G. Valerio, (unknown), Patricia A. Deuster, Gabriel I. Giancaspro	10
8	Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes 2020 ·Journal of Natural Products ·Nandakumara Sarma, Andrew Waye, Mahmoud A. ElSohly, Paula N. Brown, Sytze Elzinga, Holly E. Johnson, Robin J. Marles, Jeremy E. Melanson, Ethan B. Russo, Lawrence Deyton, Christopher Hudalla, Gordon Vrdoljak, (unknown), Ikhlas A. Khan, (unknown), Gabriel I. Giancaspro	77
9	NMR reveals an undeclared constituent in custom synthetic peptides 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·Mary Choules, Jonathan Bisson, Charlotte Simmler, James B. McAlpine, Gabriel I. Giancaspro, Anton Bzhelyansky, Matthias Niemitz, Guido F. Pauli	11
10	Quality specifications for articles of botanical origin from the United States Pharmacopeia 2018 ·Phytomedicine ·Cuiying Ma, Hellen Oketch‐Rabah, Nam-Cheol Kim, Marı́a Monagas, Anton Bzhelyansky, Nandakumara Sarma, Gabriel I. Giancaspro	17
11	The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of L-Tryptophan and L-Citrulline 2016 ·Journal of Nutrition ·Hellen Oketch‐Rabah, Amy L. Roe, Bill J. Gurley, James C. Griffiths, Gabriel I. Giancaspro	14
12	Evidence-based evaluation of potential benefits and safety of beta-alanine supplementation for military personnel 2014 ·Nutrition Reviews ·(unknown), Tieraona Low Dog, Dennis K.J. Gorecki, Louis R. Cantilena, Rebecca B. Costello, William J. Evans, Mary Hardy, Scott A. Jordan, Ronald J. Maughan, Janet Walberg Rankin, Abbie E. Smith‐Ryan, Luis G. Valerio, (unknown), Patricia A. Deuster, Gabriel I. Giancaspro, Nandakumara Sarma	12
13	United States Pharmacopeia Safety Evaluation of Spirulina 2011 ·Critical Reviews in Food Science and Nutrition ·Robin J. Marles, Marilyn Barrett, Joanne Barnes, Mary L. Chavez, Paula Gardiner, (unknown), Gail B. Mahady, Tieraona Low Dog, Nandakumara Sarma, Gabriel I. Giancaspro, Maged H. M. Sharaf, James C. Griffiths	127
14	Assessing safety of herbal products for menopausal complaints: An international perspective 2010 ·Maturitas ·Tieraona Low Dog, Robin J. Marles, Gail B. Mahady, Paula Gardiner, (unknown), Joanne Barnes, Mary L. Chavez, James C. Griffiths, Gabriel I. Giancaspro, Nandakumara Sarma	12
15	Development and validation of a dissolution test method for vitamin A in dietary supplement tablets 2010 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Erika Stippler, (unknown), Gabriel I. Giancaspro	10
16	The state of dietary supplement adverse event reporting in the United States 2008 ·Pharmacoepidemiology and Drug Safety ·Paula Gardiner, Dandapantula N. Sarma, Tieraona Low Dog, Marilyn Barrett, Mary L. Chavez, (unknown), Gail B. Mahady, Robin J. Marles, Linda S. Pellicore, Gabriel I. Giancaspro	50
17	Safety of Green Tea Extracts 2008 ·Drug Safety ·Dandapantula N. Sarma, Marilyn Barrett, Mary L. Chavez, Paula Gardiner, (unknown), Gail B. Mahady, Robin J. Marles, Linda S. Pellicore, Gabriel I. Giancaspro, Tieraona Low Dog	233
18	United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity 2008 ·Menopause The Journal of The North American Menopause Society ·Gail B. Mahady, Tieraona Low Dog, Marilyn Barrett, Mary L. Chavez, Paula Gardiner, (unknown), Robin J. Marles, Linda S. Pellicore, Gabriel I. Giancaspro, Dandapantula N. Sarma	114
19	The Development of USP Botanical Dietary Supplement Monographs, 1995−2005 2006 ·Journal of Natural Products ·Paul L. Schiff, V. Srinivasan, Gabriel I. Giancaspro, (unknown), (unknown), Maged H. M. Sharaf	15
20	[Guidelines for the management of hypertensive crises and simple blood pressure rise. Literature review and clinical experience]. 2003 ·PubMed ·Maurizio Soldini, (unknown), (unknown), (unknown), Daniel Curcio, Gabriel I. Giancaspro	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact